IOL Chemicals & Pharmaceuticals yesterday said that it has received nod from the Korean Ministry of Food and Drug Safety for its active pharmaceutical ingredient (API) products — Ibuprofen and Fenofibrate. The approval by the Korean Ministry of Food and Drug Safety re-establishes the company’s efforts to keep the highest quality standards and to increase presence in the regulated markets, the company said in a regulatory filing.
This will strengthen the company’s presence in the South Korean market, it added.
Ibuprofen is used to treat a range of aches and pains, including back pain, period pain and toothache. Fenofibrate is used to treat the symptoms of high cholesterol and triglycerides in the blood.